TRELLUS HEALTH PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 GBX | +8.57% |
|
-5.00% | -41.54% |
| 04-24 | Transcript : Trellus Health plc, Q4 2023 Earnings Call, Apr 24, 2024 | |
| 04-23 | EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat | AN |
| Sales 2021 | 0.02 2 | Sales 2022 | 0.02 1.44 | Capitalization | 19.53M 1.56B |
|---|---|---|---|---|---|
| Net income 2021 | -5M -400M | Net income 2022 | -8M -640M | EV / Sales 2021 | 2,872,307,841 x |
| Net cash position 2021 | 31.98M 2.56B | Net cash position 2022 | 19.08M 1.53B | EV / Sales 2022 | 24,968,473 x |
| P/E ratio 2021 |
-14.3
x | P/E ratio 2022 |
-2.22
x | Employees | 31 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 42.33% |
More Fundamentals
* Assessed data
More news
Latest transcript on Trellus Health plc
More press releases
| 1 day | +8.57% | ||
| 1 week | -5.00% | ||
| Current month | -15.56% | ||
| 1 month | -15.56% | ||
| 3 months | -62.00% | ||
| 6 months | -63.81% | ||
| Current year | -41.54% |
1 week
1.54
2.90
1 month
1.502.90
Current year
1.507.38
1 year
1.509.65
3 years
1.5078.00
5 years
1.5078.00
10 years
1.5078.00
| Managers | Title | Age | Since |
|---|---|---|---|
Marla Dubinsky
FOU | Founder | - | 14/07/20 |
Joy Bessenger
DFI | Director of Finance/CFO | - | 17/09/23 |
Alex Lorenzo
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Mahony
CHM | Chairman | - | - |
Erik Lium
BRD | Director/Board Member | 56 | - |
Marla Dubinsky
FOU | Founder | - | 14/07/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 1.9 | +8.57% | 1,258,055 |
| 25/04/24 | 1.75 | -12.50% | 505,066 |
| 24/04/24 | 2 | -11.11% | 559,688 |
| 23/04/24 | 2.25 | +12.50% | 2,800,045 |
| 22/04/24 | 2 | 0.00% | 437 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotes
Trellus Health plc is a United Kingdom-based digital health company. It offers a scientifically validated, personalized resilience-based self-management training program for people living with chronic conditions. It is focused on the intersection of chronic physical conditions and mental health. The Companyâs approach transforms chronic disease management and changes the lives of patients living with debilitating, incurable conditions, primarily focused on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, and irritable bowel syndrome (IBS). The TrellusElevate platform is the Company's connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Through its TrellusElevate connected care platform and companion App, the Company addresses both clinical and behavioral health together. The Companyâs wholly owned subsidiary is Trellus Health Inc.
Sector
Software
Calendar
26/09/2024
- Q2 2024 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -41.54% | 3.82M | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| -24.56% | 46.55B | |
| +31.16% | 50.15B | |
| +17.75% | 41.41B | |
| +55.21% | 35.63B | |
| -10.24% | 24.64B | |
| -21.24% | 23.04B |
- Stock Market
- Equities
- TRLS Stock
